GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (MEX:GEHC) » Definitions » Loans Receivable

GE HealthCare Technologies (MEX:GEHC) Loans Receivable : MXN0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is GE HealthCare Technologies Loans Receivable?

GE HealthCare Technologies's Loans Receivable for the quarter that ended in Dec. 2024 was MXN0 Mil.


GE HealthCare Technologies Loans Receivable Historical Data

The historical data trend for GE HealthCare Technologies's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Loans Receivable Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial - - - - -

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GE HealthCare Technologies Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


GE HealthCare Technologies Loans Receivable Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).